Peng Jiang

Dr. Peng Jiang

South China Sea Institute Of Oceanology, Guangzhou, Guangdong, China
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2023 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PJPeng Jiang
Peng Jiang
HJHongbo Jin
Hongbo Jin
GZGuangtao Zhang
Guangtao Zhang
WZWenjun Zhang
Wenjun Zhang
WLWei Liu
Wei Liu
LZLiping Zhang
Liping Zhang

30 June 2023 in Archives of Pharmacal Research
Verified
Journal Article
Closed access
PDF file
PJPeng Jiang
Peng Jiang
XFXiujuan Fu
Xiujuan Fu
HNHong Niu
Hong Niu
SCSiwei Chen
Siwei Chen
FLFeifei Liu
Feifei Liu
HLHui Lei
Hui Lei

13 November 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
PJPeng Jiang
Peng Jiang
JLJinfeng Luo
Jinfeng Luo
YJYao Jiang
Yao Jiang
LZLiping Zhang
Liping Zhang
LJliyuan jiang
liyuan jiang
HLHui Lei
Hui Lei
Five undescribed polyketide derivatives, pestaloketides A–E (1–5), along with eleven known analogues (6–16), were isolated from the sponge-derived fungus Pestalotiopsis sp. Their structures, including absolute configurations, were elucidated by analyses of NMR spectroscopic HRESIMS data and electronic circular dichroism (ECD) calculations. Compounds 5, 6, 9, and 14 exhibited weak cytotoxicities against four human cancer cell lines, with IC50 values ranging from 22.1 to 100 μM. Pestaloketide A (1) is an unusual polyketide, featuring a rare 5/10/5-fused ring system. Pestaloketides A (1) and B (2) exhibited moderately inhibited LPS-induced NO production activity, with IC50 values of 23.6 and 14.5 μM, respectively, without cytotoxicity observed. Preliminary bioactivity evaluations and molecular docking analysis indicated that pestaloketides A (1) and B (2) had the potential to be developed into anti-inflammatory activity drug leads.

22 September 2020 in Current Organic Chemistry
Verified
Journal Article
Closed access
PDF file
HLHui Lei
Hui Lei
PJPeng Jiang
Peng Jiang
DZDan Zhang
Dan Zhang
Gorgonian corals are considered as a rich source of secondary metabolites with unique structural features and biological activities. A large number of novel metabolites with potent pharmacological properties have been isolated from gorgonian corals. Some of these compounds have exhibited to possess new mechanisms of action, which hold great promises as potential lead compounds in future marine drug development. This review aims to provide an overview of chemical constituents and biological activities of gorgonian corals from 2015 to December, 2019. Some 145 metabolites, including 16 sesquiterpenoids, 62 diterpenoids, 62 steroids and 5 alkaloids were reported during this period and their pharmacological activities were investigated. Moreover, the peculiar structure and potential medicinal value of these new compounds are discussed in this review.

23 October 2024 in Chemistry – A European Journal
Verified
Journal Article
Closed access
LZLiping Zhang
Liping Zhang
PJPeng Jiang
Peng Jiang
HJHongbo Jin
Hongbo Jin
Changsheng ZhangChangsheng Zhang
Changsheng Zhang